KDA
Current issue Volume 49(3); May 2025
-
Glucagon-Like Peptide-1 and Hypothalamic Regulation of Satiation: Cognitive and Neural Insights from Human and Animal Studies
Joon Seok Park, Kyu Sik Kim, Hyung Jin Choi
Diabetes Metab J. 2025;49(3):333-347.
ReviewMay 1, 2025
-
Extracellular Vesicle-Mediated Network in the Pathogenesis of Obesity, Diabetes, Steatotic Liver Disease, and Cardiovascular Disease
Joonyub Lee, Won Gun Choi, Marie Rhee, Seung-Hwan Lee
Diabetes Metab J. 2025;49(3):348-367.
ReviewMay 1, 2025
-
Metabolic Sparks in the Liver: Metabolic and Epigenetic Reprogramming in Hepatic Stellate Cells Activation and Its Implications for Human Metabolic Diseases
Yeon Jin Roh, Hyeonki Kim, Dong Wook Choi
Diabetes Metab J. 2025;49(3):368-385.
ReviewMay 1, 2025
-
SGLT2 Inhibitors and GLP-1 Receptor Agonists in Diabetic Kidney Disease: Evolving Evidence and Clinical Application
Jae Hyun Bae
Diabetes Metab J. 2025;49(3):386-402.
ReviewMay 1, 2025
- Advancing Early Prediction of Gestational Diabetes Mellitus with Circular RNA Biomarkers Joon Ho Moon, Sung Hee Choi Diabetes Metab J. 2025;49(3):403-404. EditorialMay 1, 2025
- Addressing the Persistent Increase and Inequities in Metabolically Unhealthy Obesity: Toward an Understanding of Clinical Obesity Young Sang Lyu, Sang Yong Kim Diabetes Metab J. 2025;49(3):405-406. EditorialMay 1, 2025
-
Revealing VCAN as a Potential Common Diagnostic Biomarker of Renal Tubules and Glomerulus in Diabetic Kidney Disease Based on Machine Learning, Single-Cell Transcriptome Analysis and Mendelian Randomization
Li Jiang, Jie Jian, Xulin Sai, Xiai Wu
Diabetes Metab J. 2025;49(3):407-420.
Original ArticleJanuary 24, 2025
-
Ras Guanine Nucleotide-Releasing Protein-4 Inhibits Erythropoietin Production in Diabetic Mice with Kidney Disease by Degrading HIF2A
Junmei Wang, Shuai Huang, Li Zhang, Yixian He, Xian Shao, et al.
Diabetes Metab J. 2025;49(3):421-435.
Original ArticleJanuary 23, 2025
-
Comparison of Real-Time and Intermittently-Scanned Continuous Glucose Monitoring for Glycemic Control in Type 1 Diabetes Mellitus: Nationwide Cohort Study
Ji Yoon Kim, Seohyun Kim, Jae Hyeon Kim
Diabetes Metab J. 2025;49(3):436-447.
Original ArticleFebruary 27, 2025
-
Normalized Creatinine-to-Cystatin C Ratio and Risk of Cardiometabolic Multimorbidity in Middle-Aged and Older Adults: Insights from the China Health and Retirement Longitudinal Study
Honglin Sun, Zhenyu Wu, Guang Wang, Jia Liu
Diabetes Metab J. 2025;49(3):448-461.
Original ArticleJanuary 20, 2025
-
ReviewMay 1, 2025
Glucagon-Like Peptide-1 and Hypothalamic Regulation of Satiation: Cognitive and Neural Insights from Human and Animal Studies
Joon Seok Park, Kyu Sik Kim, Hyung Jin Choi
Diabetes Metab J. 2025;49(3):333-347.
-
ReviewMay 1, 2025
Extracellular Vesicle-Mediated Network in the Pathogenesis of Obesity, Diabetes, Steatotic Liver Disease, and Cardiovascular Disease
Joonyub Lee, Won Gun Choi, Marie Rhee, et al.
Diabetes Metab J. 2025;49(3):348-367.
-
ReviewMay 1, 2025
Metabolic Sparks in the Liver: Metabolic and Epigenetic Reprogramming in Hepatic Stellate Cells Activation and Its Implications for Human Metabolic Diseases
Yeon Jin Roh, Hyeonki Kim, Dong Wook Choi
Diabetes Metab J. 2025;49(3):368-385.
-
ReviewMay 1, 2025
SGLT2 Inhibitors and GLP-1 Receptor Agonists in Diabetic Kidney Disease: Evolving Evidence and Clinical Application
Jae Hyun Bae
Diabetes Metab J. 2025;49(3):386-402.
- EditorialMay 1, 2025 Advancing Early Prediction of Gestational Diabetes Mellitus with Circular RNA Biomarkers Joon Ho Moon, Sung Hee Choi Diabetes Metab J. 2025;49(3):403-404.
- EditorialMay 1, 2025 Addressing the Persistent Increase and Inequities in Metabolically Unhealthy Obesity: Toward an Understanding of Clinical Obesity Young Sang Lyu, Sang Yong Kim Diabetes Metab J. 2025;49(3):405-406.
- Ahead-of print
-
- Enavogliflozin, an SGLT2 Inhibitor, Improves Nonalcoholic Steatohepatitis Induced by High-Fat, High-Cholesterol Diet
- Differences between Type 2 Diabetes Mellitus and Obesity Management: Medical, Social, and Public Health Perspectives
- Assessing Nutritional Factors for Metabolic Dysfunction-Associated Steatotic Liver Disease via Diverse Statistical Tools
- Ultra-Processed Food Intake and Risk of Type 2 Diabetes Mellitus: A Dose-Response Meta-Analysis of Prospective Studies
- Most cited
-
- 2023 Clinical Practice Guidelines for Diabetes Mellitus of the Korean Diabetes Association64
- Adipose Tissue and Metabolic Health51
- Advances in Continuous Glucose Monitoring and Integrated Devices for Management of Diabetes with Insulin-Based Therapy: Improvement in Glycemic Control38
- Gestational Diabetes Mellitus and Its Implications across the Life Span38
Special thematic issues
Best paper of the year
-
Glycemia according to the Use of Continuous Glucose Monitoring among Adults with Type 1 Diabetes Mellitus in Korea: A Real-World Study You-Bin Lee, Minjee Kim, Jae Hyeon Kim
-
Metabolic Dysfunction-Associated Fatty Liver Disease and Mortality: A Population-Based Cohort Study Kyung-Soo Kim, Sangmo Hong, Hong-Yup Ahn, et al.
-
Effect of Lactobacillus plantarum LMT1-48 on Body Fat in Overweight Subjects: A Randomized, Double-Blind, Placebo-Controlled Trial Minji Sohn, Hyeyoung Jung, Woo Shun Lee, et al.
-
Cardiovascular Outcomes according to Comorbidities and Low-Density Lipoprotein Cholesterol in Korean People with Type 2 Diabetes Mellitus Min Kyong Moon, Junghyun Noh, Eun-Jung Rhee, et al.
Recent Issues
Volume 49(2); Mar 2025 
Volume 49(1); Jan 2025 
Volume 48(6); Nov 2024 
Volume 48(5); Sep 2024 
Volume 48(4); Jul 2024 
Volume 48(3); May 2024 
Volume 48(2); Mar 2024 
Volume 48(1); Jan 2024 
Volume 47(6); Nov 2023 
Volume 47(5); Sep 2023 
Volume 47(4); Jul 2023 
